Role of Pharmacist Counseling in Preventing Adverse Drug Events After Hospitalization
نویسندگان
چکیده
منابع مشابه
Role of pharmacist counseling in preventing adverse drug events after hospitalization.
BACKGROUND Hospitalization and subsequent discharge home often involve discontinuity of care, multiple changes in medication regimens, and inadequate patient education, which can lead to adverse drug events (ADEs) and avoidable health care utilization. Our objectives were to identify drug-related problems during and after hospitalization and to determine the effect of patient counseling and fol...
متن کاملPreventing drug-related adverse events following hospital discharge: the role of the pharmacist
Transition of care (ToC) points, and in particular hospital admission and discharge, can be associated with an increased risk of adverse drug events (ADEs) and other drug-related problems (DRPs). The growing recognition of the pharmacist as an expert in medication management, patient education and communication makes them well placed to intervene. There is evidence to indicate that the inclusio...
متن کاملClinical Pharmacist’s Role in Preventing Adverse Drug Events: Brief Update Review
Introduction In our original report, “Making Health Care Safer” 2001, Kaushal and Bates noted that over 770,000 people were harmed or died in hospitals annually from adverse drug events (ADE), with incidence rates in hospital-based studies ranging from 2 to 7 per 100 admissions. In the outpatient setting, as they also noted, one study on adults estimated the ADE incidence rate at 3 percent. The...
متن کاملChapter 7. The Clinical Pharmacist’s Role in Preventing Adverse Drug Events
A large literature documents the multiple roles clinical pharmacists can play in a variety of health care settings. Much of this literature focuses on measures of impact not directly relevant to this Report – eg, economic benefits, patient compliance, and drug monitoring. More recently, systems-based analyses of medication errors and adverse drug events (ADEs) have drawn attention to the impact...
متن کاملPharmacist reporting of serious adverse drug events to the Food and Drug Administration.
OBJECTIVE To identify barriers to and facilitators of pharmacist reporting of serious adverse drug events (ADEs) to the Food and Drug Administration (FDA). METHOD Two focus groups consisting of practicing pharmacists were held in Austin, TX, in 2009. The following open-ended questions were used in the focus groups: (1) What do you think would make it easier to report serious ADEs to the FDA? ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Internal Medicine
سال: 2006
ISSN: 0003-9926
DOI: 10.1001/archinte.166.5.565